The correlation between inflammatory injury induced by LPS and RAS in EpH4-Ev cells

International Immunopharmacology

Volumn 46, Issue , 2017, Pages 23-30

  Wang, Kun ^a   Liu, Xiaoqian ^a   Xiao, Hang ^a   Wang, Huanhuan ^a   Zhang, Yuanshu ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

ACE2; Inflammatory injury; LPS; Mammary gland cells; RAS

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; INTERLEUKIN 8; RAS PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM CELL; CELL DAMAGE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; INFLAMMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING; ANIMAL; CELL LINE; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MAMMARY GLAND; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CELL LINE; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MAMMARY GLANDS, HUMAN; MICE; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85013891183     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2017.02.016     Document Type: Article

References (35)

1. [1] Schmieder, R.E., Hilgers, K.F., Schlaich, M.P., Schmidt, B.M., Reninangiotensin system and cardiovascular risk. Lancet 369 (2007), 1208–1219.
2. [2] Castrop, H., Hocherl, K., Kurtz, A., Schweda, F., Todorov, V., Wagner, C., Physiology of kidney renin. Physiol. Rev. 90 (2010), 607–673.
3. [3] Donoghue, M., Hsieh, F., Baronas, E., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87:5 (2000 Sep 1), E1–E9.
4. [4] Tipnis, S.R., Hooper, N.M., Hyde, R., et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275:43 (2000 Oct 27), 33238–33243.
5. [5] Santos, R.A., Ferreira, A.J., Verano-Braga, T., et al. Angiotensin-converting enzyme 2, angiotensin-(1-7) and mas: new players of the renin-angiotensin system. J. Endocrinol. 216:2 (2013 Jan 18), R1–R17.
6. [6] Santos RA, Simoes e Silva AC, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U. S. A. 2003 Jul 8;100(14):8258–63.
7. [7] Chappell, M.C., Nonclassical renin-angiotensin system and renal function. Comput. Phys. 2:4 (2012 Oct), 2733–2752.
8. [8] Oudit, G.Y., Kassiri, Z., Patel, M.P., et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc. Res. 75:1 (2007 Jul 1), 29–39.
9. [9] Crackower, M.A., Sarao, R., Oudit, G.Y., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:6891 (2002 Jun 20), 822–828.
10. [10] He, H.L., Liu, L., Chen, Q.H., et al. MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS. J. Cell. Physiol. 230:3 (2015 Mar), 691–701.
11. [11] Zhong, J., Guo, D., Chen, C.B., et al. Prevention of angiotensin II–mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 57:2 (2011 Feb), 314–322.
12. [12] Imai, Y., Kuba, K., Rao, S., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:7047 (2005 Jul 7), 112–116.
13. [13] Hashimoto, T., Perlot, T., Rehman, A., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487:7408 (2012 Jul 25), 477–481.
14. [14] Paizis, G., Tikellis, C., Cooper, M.E., et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54:12 (2005 Dec), 1790–1796.
15. [15] Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., et al. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35:6 (2003 Jun), 881–900.
16. [16] Wang, J., Liu, R., Qi, H., et al. The ACE2-angiotensin-(1-7)-mas axis protects against pancreatic cell damage in cell culture. Pancreas 44:2 (2015 Mar), 266–272.
17. [17] Li, Y., Cao, Y., Zeng, Z., et al. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways. Sci. Rep., 5, 2015 Feb 3, 8209.
18. [18] Yu, C., Tang, W., Wang, Y., et al. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry. Cancer Lett. 376:2 (2016 Jul 1), 268–277.
19. [19] Luo, Y., Tanabe, E., Kitayoshi, M., et al. Expression of MAS1 in breast cancer. Cancer Sci. 106:9 (2015 Sep), 1240–1248.
20. [20] Akira, S., Takeda, K., Toll-like receptor signaling. Nat. Rev. Immunol. 4:7 (2004 Jul), 499–511.
21. [21] Oviedo-Boyso, J., Valdez-Alarcón, J.J., Cajero-Juárez, M., et al. Innate immune response of bovine mammary gland to pathogenic bacteria responsible for mastitis. J Infect. 54:4 (2007 Apr), 399–409.
22. [22] Yang, Z., Yin, R., Cong, Y., et al. Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-κB and MAPKs signaling pathways. Inflammation 37:6 (2014 Dec), 2047–2055.
23. [23] Li, X., Li, Z., Hou, D., et al. The bovine endometrial epithelial cells promote the differentiation of trophoblast stem-like cells to binucleate trophoblast cells. Cytotechnology, 2016 Jul 29.
24. [24] O'Sullivan, A.W., Wang, J.H., Redmond, H.P., NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J. Surg. Res. 152:1 (2009 Mar), 46–53.
25. [25] Sakthivel, P., Ilangovan, A., Kaushik, M.P., Natural product-inspired rational design, synthesis and biological evaluation of 2,3-dihydropyrano[2,3-f]chromen-4(8H)-one based hybrids as potential mitochondrial apoptosis inducers. Eur. J. Med. Chem. 122 (2016 Jun 27), 302–318.
26. [26] Huentelman, M.J., Zubcevic, J., Katovich, M.J., et al. Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul. Pept. 122:2 (2004 Oct 15), 61–67.
27. [27] Wong, M.H., Chapin, O.C., Johnson, M.D., LPS-stimulated cytokine production in type I cells is modulated by the renin-angiotensin system. Am. J. Respir. Cell Mol. Biol. 46:5 (2012 May), 641–650.
28. [28] Wösten-van Asperen, R.M., Lutter, R., Specht, P.A., et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 225:4 (2011), 618–627 Dec.
29. [29] Kurihara, T., Ozawa, Y., Shinoda, K., et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest. Ophthalmol. Vis. Sci. 47:12 (2006 Dec), 5545–5552.
30. [30] Santos, S.H., Andrade, J.M., Fernandes, L.R., et al. Oral angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet. Peptides 46 (2013 Aug), 47–52.
31. [31] Li, Y., Zeng, Z., Cao, Y., et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci. Rep., 6, 2016 Jun 15, 27911.
32. [32] Tao, L., Qiu, Y., Fu, X., et al. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. J. Neuroinflammation, 13, 2016 Feb 9, 35.
33. [33] Hagiwara, S., Iwasaka, H., Matumoto, S., et al. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit. Care Med. 37:2 (2009 Feb), 626–633.
34. [34] Gupta, A., Rhodes, G.J., Berg, D.T., et al. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am. J. Physiol. Ren. Physiol. 293:1 (2007 Jul), F245–F254.
35. [35] Zhang, H., Sun, G.Y., LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch. Biochem. Biophys. 441:1 (2005 Sep 1), 75–83.